Stem Cell Therapy for Crohn's Disease in Istanbul

The gastroenterology review, laboratory work, the number of infusions and the monitoring during your stay are quoted line by line rather than as a single package figure, since the case review decides which of them your file actually needs. Our patient coordination team confirms the itemized plan in writing before flights are booked, and states the position in advance if disease activity means treatment has to be deferred after you arrive.

Crohn's has one of the longer research relationships with these cells of any condition we treat, and the immune rationale behind it is one our medical team is confident explaining. It runs in two directions that should never be blurred together: local placement around perianal fistulas, and systemic infusion aimed at immune signalling. Responses differ between patients, so your plan is written as goals with measurements attached - and what your calprotectin, CRP and symptom scores do afterwards is the answer that applies to you.

Your written plan states it before you commit to flights: the assessment on arrival, the number of infusions, the observation after each one, and the checks our team repeats where there has been recent disease activity. Our patient coordination team confirms dates and daily timings in writing, and builds the schedule around bathroom access and travel comfort rather than pretending those do not matter.

Alongside it. Nothing in this plan is a reason to stop infliximab, adalimumab, ustekinumab, vedolizumab or an immunomodulator, and coming off a biologic that is holding your disease is how people lose remission - our medical team will not propose it, and will not proceed if you have stopped one in order to travel. What we do review is timing: when your last dose was given, when the next is due, your infection screening and your current disease activity, so the infusion is scheduled sensibly around all four. The plan is shared with your gastroenterologist so both sides are working from the same file.

Yes. Our regenerative medicine program works with mesenchymal stromal cells (MSCs) grown from Wharton's jelly, the gelatinous tissue inside the umbilical cord. It is donated after a healthy birth with written maternal consent, from tissue that would otherwise be discarded, so nothing is taken from mother or baby and none of the ethical questions attached to embryonic sources arise. Because these cells expand readily in culture, a batch is characterised and release-tested before it reaches anyone. Your written plan names the material, how it is prepared, the dose, the route of administration and the schedule, and our medical team explains why each of those was chosen for your case.

Wharton's jelly is a young, perinatal tissue rather than an adult one, so the starting material does not carry the age or the health history of the person being treated, and nothing has to be harvested from you on the day. These cells also have a low-immunogenicity profile, which is why this source is studied for use between unrelated people. Most of all, they are strong secretors: the signalling molecules MSCs release are the mechanism most current research centres on, and that is what a plan is built around.

The length of stay follows your plan: the route of administration, the number of sessions, the monitoring after each one, and any mobility or assistance you need. Our patient coordination team confirms appointment dates, daily timings and the expected length of the visit in writing before you book flights.

No medical procedure is free of risk. Our medical team screens for infection, bleeding risk, medication interactions and other contraindications before treatment, explains the risks specific to the route used in your plan, and monitors you during administration and afterwards. If something makes treatment unsafe for you, we say so instead of proceeding.

Goals are set with you and described as aims, not results. Regenerative medicine treatments are planned individually, responses vary between patients and no clinical outcome can be guaranteed. Your plan states what will be measured, when it will be reviewed, and how treatment sits alongside the care you already receive.

Send your confirmed diagnosis, recent reports and imaging, your current medication list, previous procedures and the goals that matter to you. Our medical team reviews them remotely and comes back with an assessment of whether treatment in Istanbul is appropriate for your case, and what the next step would be.